U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07610577) titled 'Use and Costs of P2Y12 Inhibitors After Acute Myocardial Infarction' on May 20.
Brief Summary: This study aims to describe temporal trends in the use and costs of clopidogrel, ticagrelor, and prasugrel in Germany and the United States.
Study Start Date: Nov. 01, 2025
Study Type: OBSERVATIONAL
Condition:
Acute Myocardial Infarction (AMI)
Intervention:
DRUG: Clopidogrel
Initiation of clopidogrel in healthcare claims is used as the exposure.
DRUG: Prasugrel
Initiation of prasugrel in healthcare claims is used as the exposure.
DRUG: Ticagrelor
Initiation of ticagrelor in healthcare claims is used as the exposure.
Recruitment ...